Ghofrani HA, Seeger W, Grimminger F Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med. 2005 Sep 29;353(13):1412-3.
Haugeberg G, Brodin C, Johnsen V [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs]. Tidsskr Nor Laegeforen. 1995 Nov 30;115(29):3619-21. Norwegian.
Nadashkevich O, Davis P, Fritzler MJ A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit. 2004 Nov;10(11):CR615-21. Epub 2004 Oct 26.
Newell DR How to develop a successful cancer drug--molecules to medicines or targets to treatments? Eur J Cancer. 2005 Mar;41(5):676-82. Review.
Thompson AE, Pope JE Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol. 2002 Sep;29(9):1867-73.
A Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
